Peynircio臒lu B, Hizal M, Cil B, Deuerling-Zheng Y, Von Roden M, Hazirolan T, Akata D, Ozmen M, Balkanci F. Quantitative liver tumor blood volume measurements by a C-arm CT post-processing software before and after hepatic arterial embolization therapy: comparison with MDCT perfusion. ...
Click on the tumor marker to go to the test article for more details on a particular marker. Tumor markerAssociated cancer(s)Usual sampleUse(s)Comments AFP (Alpha-feto protein) Certain liver, ovarian, testicular Blood Helps diagnose, monitors treatment and for recurrence Also elevated during ...
For the Edmondson grade, calculations were performed per biopsy, whereas all other parameters were calculated per patient. ALD, alcoholic liver disease; AFP, alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; HBV, hepatitis B virus; HCV, hepatitis C virus; MVI, macrovascular invasion; NAFLD,...
The tumor microenvironment (TME) is comprised of non-malignant cells that interact with each other and with cancer cells, critically impacting cancer biology. The TME is complex, and understanding it requires simplifying approaches. Here we provide an ex
Although nutrition-starvation therapy for malignancies such as HNSCC is highly desirable, the clinical outcomes remain disappointing. Understanding the spatial heterogeneity of glucose deficiency can reveal the molecular mechanisms regulating cancer meta
Originally thought that CEAis a specific marker of colorectal cancer and other malignant tumorssubsequently found in endodermal layer cells can also be positive to the.Further studies have shown that blood levels of CEA increase in some benign andother non neoplastic diseases. Therefore, CEA is a...
Rational design of smart nanosystems with high biological safety is a critical milestone for realizing precise imaging-guided cancer theranostics. Herein, a bioinspired nanosystem was designed by camouflaging SPIO@DOX-ICG nanoparticles with cancer cell m
Macrophages are white blood cells that accumulate in tumors, where they aid cancer progression. Now scientists have identified a surface protein found only on the macrophages residing in tumors, exposing a target for precise tumor treatments.
To date, there have not been great breakthroughs in immunotherapy for HER2 positive breast cancer (HPBC). This study aimed to build a risk model that might contribute to predicting prognosis and discriminating the immune landscape in patients with HPBC.
Another study found that the normalized uptake of SUVmax to liver has the most significant impact on the pathologic complete response in patients with locally advanced rectal cancer after receiving neoadjuvant chemotherapy [15]. Seunghyeon et al. found that the standardized uptake tumor-to-blood ...